224 related articles for article (PubMed ID: 34500749)
1. Imidazopyridazine Acetylcholinesterase Inhibitors Display Potent Anti-Proliferative Effects in the Human Neuroblastoma Cell-Line, IMR-32.
Sharma RK; Singh M; Ghimeray K; Juneja P; Dev G; Pulavarthi S; Reddy SR; Akundi RS
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500749
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights.
Sabt A; Eldehna WM; Al-Warhi T; Alotaibi OJ; Elaasser MM; Suliman H; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1616-1630. PubMed ID: 32781872
[TBL] [Abstract][Full Text] [Related]
4. Development of pyridazine derivatives as potential EGFR inhibitors and apoptosis inducers: Design, synthesis, anticancer evaluation, and molecular modeling studies.
Ahmed MF; Santali EY; Mohi El-Deen EM; Naguib IA; El-Haggar R
Bioorg Chem; 2021 Jan; 106():104473. PubMed ID: 33243490
[TBL] [Abstract][Full Text] [Related]
5. Aminopyridazines as acetylcholinesterase inhibitors.
Contreras JM; Rival YM; Chayer S; Bourguignon JJ; Wermuth CG
J Med Chem; 1999 Feb; 42(4):730-41. PubMed ID: 10052979
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
Saeed A; Mahesar PA; Zaib S; Khan MS; Matin A; Shahid M; Iqbal J
Eur J Med Chem; 2014 May; 78():43-53. PubMed ID: 24675179
[TBL] [Abstract][Full Text] [Related]
7. Probing simple structural modification of α-mangostin on its cholinesterase inhibition and cytotoxicity.
Khaw KY; Kumar P; Yusof SR; Ramanathan S; Murugaiyah V
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000156. PubMed ID: 32716578
[TBL] [Abstract][Full Text] [Related]
8. A facile stereoselective synthesis of dispiro-indeno pyrrolidine/pyrrolothiazole-thiochroman hybrids and evaluation of their antimycobacterial, anticancer and AchE inhibitory activities.
Bharkavi C; Vivek Kumar S; Ashraf Ali M; Osman H; Muthusubramanian S; Perumal S
Bioorg Med Chem; 2016 Nov; 24(22):5873-5883. PubMed ID: 27687968
[TBL] [Abstract][Full Text] [Related]
9. Identification of 2-substituted pyrrolo[1,2-b]pyridazine derivatives as new PARP-1 inhibitors.
Xiang HY; Chen JY; Huan XJ; Chen Y; Gao ZB; Ding J; Miao ZH; Yang CH
Bioorg Med Chem Lett; 2021 Jan; 31():127710. PubMed ID: 33246105
[TBL] [Abstract][Full Text] [Related]
10. Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity.
Kusakabe K; Ide N; Daigo Y; Itoh T; Yamamoto T; Hashizume H; Nozu K; Yoshida H; Tadano G; Tagashira S; Higashino K; Okano Y; Sato Y; Inoue M; Iguchi M; Kanazawa T; Ishioka Y; Dohi K; Kido Y; Sakamoto S; Ando S; Maeda M; Higaki M; Baba Y; Nakamura Y
J Med Chem; 2015 Feb; 58(4):1760-75. PubMed ID: 25625617
[TBL] [Abstract][Full Text] [Related]
11. Design of new disubstituted imidazo[1,2-
Elie J; Feizbakhsh O; Desban N; Josselin B; Baratte B; Bescond A; Duez J; Fant X; Bach S; Marie D; Place M; Ben Salah S; Chartier A; Berteina-Raboin S; Chaikuad A; Knapp S; Carles F; Bonnet P; Buron F; Routier S; Ruchaud S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1840-1853. PubMed ID: 33040634
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine derivatives as mTOR inhibitors.
Mao B; Gao S; Weng Y; Zhang L; Zhang L
Eur J Med Chem; 2017 Mar; 129():135-150. PubMed ID: 28235701
[TBL] [Abstract][Full Text] [Related]
13. New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents.
Roldán-Peña JM; Alejandre-Ramos D; López Ó; Maya I; Lagunes I; Padrón JM; Peña-Altamira LE; Bartolini M; Monti B; Bolognesi ML; Fernández-Bolaños JG
Eur J Med Chem; 2017 Sep; 138():761-773. PubMed ID: 28728108
[TBL] [Abstract][Full Text] [Related]
14. Pyrazole[3,4-d]pyridazine derivatives: Molecular docking and explore of acetylcholinesterase and carbonic anhydrase enzymes inhibitors as anticholinergics potentials.
Taslimi P; Türkan F; Cetin A; Burhan H; Karaman M; Bildirici I; Gulçin İ; Şen F
Bioorg Chem; 2019 Nov; 92():103213. PubMed ID: 31470200
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Bioevaluation of Two Series of 3-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]quinazolin-4(3H)-ones and N-(1-Benzylpiperidin-4-yl)quinazolin-4-amines.
Lan TT; Anh DT; Pham-The H; Dung DTM; Park EJ; Jang SD; Kwon JH; Kang JS; Thuan NT; Han SB; Nam NH
Chem Biodivers; 2020 Jul; 17(7):e2000290. PubMed ID: 32356584
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Biological Evaluation of New 1,3,4-Oxadiazoles as Potential Anticancer Agents and Enzyme Inhibitors.
Yurttaş L; Çavuşoğlu BK; Çiftçi GA; Temel HE
Anticancer Agents Med Chem; 2018; 18(6):914-921. PubMed ID: 29577865
[TBL] [Abstract][Full Text] [Related]
18. Exploration of the imidazo[1,2-b]pyridazine scaffold as a protein kinase inhibitor.
Bendjeddou LZ; Loaëc N; Villiers B; Prina E; Späth GF; Galons H; Meijer L; Oumata N
Eur J Med Chem; 2017 Jan; 125():696-709. PubMed ID: 27721154
[TBL] [Abstract][Full Text] [Related]
19. Thiazolo[4,5-d]pyridazine analogues as a new class of dihydrofolate reductase (DHFR) inhibitors: Synthesis, biological evaluation and molecular modeling study.
Ewida MA; Abou El Ella DA; Lasheen DS; Ewida HA; El-Gazzar YI; El-Subbagh HI
Bioorg Chem; 2017 Oct; 74():228-237. PubMed ID: 28865294
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
Utku S; Gökçe M; Orhan I; Sahin MF
Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
